Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective

Biosimilars have been available in the USA for over a decade, and in Europe for almost two decades. In that time, biosimilars have become established in the treatment landscape for a wide range of diseases, facilitating patient access and affordability of healthcare. However, patients can still stru...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Hillel P., Turner, Matthew, McCabe, Dorothy, Woollett, Gillian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432323/
https://www.ncbi.nlm.nih.gov/pubmed/37542600
http://dx.doi.org/10.1007/s40259-023-00619-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432323/
https://www.ncbi.nlm.nih.gov/pubmed/37542600
http://dx.doi.org/10.1007/s40259-023-00619-0

Ejemplares similares